✦ LIBER ✦

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

Book ID: 118748891
Publisher: Massachusetts Medical Society
Year: 2011
Tongue: English
Weight: 679 KB
Volume: 364
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1102673

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranibizumab for Neovascular Age-Related

Ranibizumab for Neovascular Age-Related Macular Degeneration

✍ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 299 KB

Ranibizumab for Neovascular Age-Related

Ranibizumab for Neovascular Age-Related Macular Degeneration

✍ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 299 KB

## Background: Ranibizumab--a recombinant, humanized, monoclonal antibody fab that neutralizes all active forms of vascular endothelial growth factor a--has been evaluated for the treatment of neovascular age-related macular degeneration. ## Methods: In this multicenter, 2-year, double-blind, sha

Intravitreal anti-VEGF therapy in neovas

Intravitreal anti-VEGF therapy in neovascular age-related macular degeneration: Bevacizumab versus Ranibizumab

✍ C. Zehetner; M. T. Kralinger; G. F. Kieselbach 📂 Article 📅 2008 🏛 Springer Vienna 🌐 German ⚖ 219 KB

Ranibizumab for retinal angiomatous prol

Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration

✍ Timothy Y. Y. Lai; Wai-Man Chan; David T. Liu; Dennis S. Lam 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 205 KB

Ranibizumab for Age-related Macular Dege

Ranibizumab for Age-related Macular Degeneration

✍ Michael I. Seider; Jay M. Stewart 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Neovascular Age-Related Macular Degenera

Neovascular Age-Related Macular Degeneration

✍ Veritti, Daniele; Sarao, Valentina; Lanzetta, Paolo 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 187 KB